Zacks Company Profile for Merit Medical Systems, Inc. (MMSI : NSDQ) |
|
|
|
Company Description |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Number of Employees: 7,400 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $93.51 |
Daily Weekly Monthly
 |
20 Day Moving Average: 544,673 shares |
Shares Outstanding: 59.10 (millions) |
Market Capitalization: $5,526.40 (millions) |
Beta: 0.65 |
52 Week High: $111.45 |
52 Week Low: $82.62 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-0.80% |
-4.88% |
12 Week |
-2.38% |
-14.46% |
Year To Date |
-3.32% |
-8.69% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Fred P. Lampropoulos - President; Chief Executive Officer and Director
Raul Parra - Chief Financial Officer and Treasurer
F. Ann Millner - Director
Lonny J. Carpenter - Director
Stephen C. Evans - Director
|
|
Peer Information
Merit Medical Systems, Inc. (ITRJ)
Merit Medical Systems, Inc. (BRLI.)
Merit Medical Systems, Inc. (GOGY)
Merit Medical Systems, Inc. (PSTX.)
Merit Medical Systems, Inc. (ELGXQ)
Merit Medical Systems, Inc. (CAH)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 589889104
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
|
|
Share - Related Items
Shares Outstanding: 59.10
Most Recent Split Date: 5.00 (1.25:1)
Beta: 0.65
Market Capitalization: $5,526.40 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $0.69 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $2.95 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: 10.28% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/07/25 |
|
|
|
|